Cyclopropylboronic acid → 1-(3-Cyclopropyl-5-trifluoromethylpyridin-2-yl)piperazine hydrochloride
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[C:19]([Cl:20])=[CH:18][C:17]([C:21]([F:24])([F:23])[F:22])=[CH:16][N:15]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.[CH:25]1(B(O)O)[CH2:27][CH2:26]1>>[ClH:20].[CH:25]1([C:19]2[C:14]([N:11]3[CH2:10][CH2:9][NH:8][CH2:13][CH2:12]3)=[N:15][CH:16]=[C:17]([C:21]([F:22])([F:23])[F:24])[CH:18]=2)[CH2:27][CH2:26]1Participants
3
Procedure
By reaction and treatment in the same manner as in Preparation Example 49 and using 4-(3-chloro-5-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid tert-butyl ester (7.3 g), which is the intermediate described in Preparation Example 51, and cyclopropylboronic acid (4.2 g), the title compound (5.8 g) was obtained.
Workup
- customBy reaction and treatment in the same manner
- customas in Preparation Example 49
Sources & evidence
- ORD record
- ord-2fe81650481245789a299cf27e8a016c
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…